We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

55 hedge funds and large institutions have $7.58M invested in Cardiff Oncology in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

337% more call options, than puts

Call options by funds: $363K | Put options by funds: $83K

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

4% more funds holding

Funds holding: 53 → 55 (+2)

1.36% less ownership

Funds ownership: 13.41% → 12.05% (-1.4%)

14% less capital invested

Capital invested by funds: $8.81M → $7.58M (-$1.22M)

47% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 15

Holders
55
Holders Change
+2
Holders Change %
+3.77%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
15
Closed
4
Calls
$363K
Puts
$83K
Net Calls
+$280K
Net Calls Change
+$375K

Top Buyers

Rank Fund Capital Flow
1
MCM
MAI Capital Management
Ohio
+$379K
2
TSS
Two Sigma Securities
New York
+$33.7K
3
CC
Callan Capital
California
+$29.6K
4
JP Morgan Chase
JP Morgan Chase
New York
+$29.6K
5
Simplex Trading
Simplex Trading
Illinois
+$26.2K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$457K
2
Renaissance Technologies
Renaissance Technologies
New York
-$265K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$222K
4
Citadel Advisors
Citadel Advisors
Florida
-$145K
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$98.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
26
Atom Investors
Texas
$25.4K – – –
DWM
27
Denver Wealth Management
Colorado
$25.3K – – –
JP Morgan Chase
28
JP Morgan Chase
New York
$24.4K +$29.6K +17,528 +67,415%
Charles Schwab
29
Charles Schwab
California
$22.8K – – –
FWS
30
FinDec Wealth Services
California
$22.2K – – –
HighTower Advisors
31
HighTower Advisors
Illinois
$21K – – –
Simplex Trading
32
Simplex Trading
Illinois
$21K +$26.2K +15,551 New
TIM
33
Tortoise Investment Management
New York
$20.9K – – –
GIA
34
Gladstone Institutional Advisory
Florida
$20.9K +$1.69K +1,000 +7%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$19.9K – – –
Dimensional Fund Advisors
36
Dimensional Fund Advisors
Texas
$19.7K -$28.8K -17,093 -55%
Wells Fargo
37
Wells Fargo
California
$10.8K +$7 +4 +0.1%
AFIA
38
America First Investment Advisors
Nebraska
$5.56K – – –
Fidelity Investments
39
Fidelity Investments
Massachusetts
$2.19K -$1.63K -966 -38%
PNC Financial Services Group
40
PNC Financial Services Group
Pennsylvania
$2.11K – – –
Osaic Holdings
41
Osaic Holdings
Arizona
$1.17K -$1.22K -725 -46%
MWA
42
Moser Wealth Advisors
Washington
$1.12K +$1.36K +806 New
TRCT
43
Tower Research Capital (TRC)
New York
$500 +$607 +360 New
EBA
44
Eagle Bay Advisors
New York
$471 – – –
GRP
45
Global Retirement Partners
California
$413 – – –
Fifth Third Bancorp
46
Fifth Third Bancorp
Ohio
$278 – – –
NFSG
47
Newbridge Financial Services Group
Florida
$160 – – –
US Bancorp
48
US Bancorp
Minnesota
$152 – – –
AF
49
Allworth Financial
California
$139 – – –
NA
50
NewEdge Advisors
Louisiana
$113 – – –
1
2
3

CRDF Hedge Fund Activity: Q3 2023 in Review

55 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q3 2023, worth a combined $7.58M — down 14% from $8.81M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CRDF positions and 4 closed out — a net gain of 3 holders — while 8 added to existing stakes and 15 trimmed.

The largest buyer was MAI Capital Management, opening a new position worth an estimated $379K. The largest seller was GSA Capital Partners, cutting an estimated $457K.

  • 55 institutional investors held Cardiff Oncology (CRDF) as of Q3 2023, up from 53 in Q2 2023.
  • Funds reported $7.58M of Cardiff Oncology stock for Q3 2023, down 14% quarter-over-quarter.
  • 7 funds opened new Cardiff Oncology positions in Q3 2023 and 4 closed out, a net change of +3 holders.
  • The largest Cardiff Oncology buyer in Q3 2023 was MAI Capital Management, an estimated $379K added.
  • The largest Cardiff Oncology seller in Q3 2023 was GSA Capital Partners, an estimated $457K sold.

Based on aggregated 13F filings for Q3 2023.